Chia Tai Tianqing Pharmaceutical Group Co.,Ltd;Centaurus BioPharma Co., Ltd.;Lianyungang Runzhong Pharmaceutical Co., Ltd.
发明人:
申请号：
EP17747001.0
公开号：
EP3412669A1
申请日:
2017.02.04
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present applicationpresent application relates to a compound represented by Formula (III) or a pharmaceutically acceptable salt, solvent compound, active metabolite, crystal polymorph, ester, isomer, or prodrug thereof. The application further provides a pharmaceutical composition comprising the compound represented by Formula (III) and a use thereof for preparing a bromodomain inhibitor for preventing or treating various diseases, such as inflammation and cancer, related to the bromodomain.
